The Chosun Ilbo on MSN

Vanoglipel emerges as dual MASH-diabetes treatment with combination potential

Following the success of obesity treatments, global pharmaceutical and biotech industries are increasingly focusing on the ...
The American Journal of Managed Care

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...
pharmaphorum

EMA panel endorses AI for MASH clinical trials

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver ...
Medical Xpress

MASH discovery redefines subtypes with distinct risks: Findings could shape future of fatty liver disease treatment

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), impacts roughly 30% of the global adult population. The disease ...
The Manila Times

Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH

SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as 'Ribo'), in ...
Forbes

NFL Legend Dan Marino Talks About His MASH, Liver Disease Diagnosis

NEW YORK, NEW YORK - JUNE 21: Dan Marino speaks onstage at Fanatics Fest NYC 2025 at Javits Center on June 21, 2025 in New York City. (Photo by Slaven Vlasic/Getty Images) To say that Dan Marino has ...